Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice
Open Access
- 15 February 2005
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 191 (4) , 507-514
- https://doi.org/10.1086/427242
Abstract
Background. Severe acute respiratory syndrome (SARS) remains a significant public health concern after the epidemic in 2003. Human monoclonal antibodiKeywords
This publication has 23 references indexed in Scilit:
- Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with ReceptorJournal of Virology, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in ChinaScience, 2004
- A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2Journal of Biological Chemistry, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Identification of a Receptor-Binding Domain of the Spike Glycoprotein of Human Coronavirus HCoV-229EJournal of Virology, 2003
- Coronavirus Spike Proteins in Viral Entry and PathogenesisVirology, 2001
- Advances in surface plasmon resonance biosensor analysisCurrent Opinion in Biotechnology, 2000
- A Direct Comparison of the Activities of Two Humanized Respiratory Syncytial Virus Monoclonal Antibodies: MEDI‐493 and RSHZl9The Journal of Infectious Diseases, 1999
- Micro-color test for assay of transmissible gastroenteritis virus-neutralizing antibodiesArchiv für die gesamte Virusforschung, 1971